EU Gives Green Light to Toujeo, a Better Insulin Glargine?EU Gives Green Light to Toujeo, a Better Insulin Glargine?

Sanofi's U-300, or ultralong-acting insulin glargine, Toujeo has been given a positive opinion by the CHMP of the European Medicines Agency. The product is designed to improve on Lantus. International Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news